Van Den Berg Management I’s Biostage, Inc. Common Stock BSTG Stock Holding History

Van Den Berg Management I’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-29,565	Closed	-$140K	–	123
2013 Q4	$140K	Buy	+29,565	New	+$138K	0.01%	103

Other funds holding BSTG

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Van Den Berg Management I's BSTG Position: Q1 2014 in Review

Van Den Berg Management I sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2014, closing a stake of 29,565 shares — an estimated $140K sold.

Van Den Berg Management I first reported a position in BSTG in Q4 2013 and held it in 1 quarter. The position peaked at $140K in Q4 2013. 51 funds tracked by Wall St. Rank hold BSTG as of Q1 2014.

Van Den Berg Management I reported no remaining Biostage, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
Van Den Berg Management I sold 29,565 Biostage, Inc. Common Stock shares in Q1 2014, an estimated $140K.
Van Den Berg Management I first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
Van Den Berg Management I's Biostage, Inc. Common Stock position peaked at $140K in Q4 2013.
51 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2014.

Based on Van Den Berg Management I's 13F filing for Q1 2014, filed 15 May 2014.